IP Library Granted Patent US 7,674,586
Granted Patent B2
US 7,674,586 · App. 11/620,390 · Granted Mar 9, 2010

Methods of identifying modulators of L-glutamate-gated chloride channel proteins from

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,674,586
App. No.
11/620,390
Granted
Mar 9, 2010
Kind
B2
Abstract

The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.

Claims (13)

1. A method of identifying a modulator of a GluCl channel protein, comprising:

(a) contacting a test compound in the presence and absence of a R. sanguineus GluCl channel protein selected from the group consisting of SEQ ID NO:2, SEQ ID NO;4, and SEQ ID NO:6;

(b) measuring the effect of the test compound the presence and absence of the R. sanguineus GluCl channel protein of (a), wherein the effect that is measured is selected from the group consisting of: the expression of DNA encoding the R. sanguineus GluCl channel protein of (a), the expression of RNA encoding the R. sanguineus GluCl channel protein of (a), and a channel activity of the R. sanguineus GluCl channel protein of (a); and

(c) comparing the effect of the test compound in the presence and absence of the R. sanguineus GluCl channel protein,

wherein if the effect of the test compound measured in the presence of the R. sanguineus GluCl channel protein is greater than or less than the effect measured in the absence of the R. sanguineus GluCl channel protein, the test compound is a modulator of a GluCl channel protein.

2. The method of claim 1 wherein the host cell that expresses the R. sanguineus GluCl channel protein of step (a) is a recombinant host cell.

3. A method of identifying a compound that modulates glutamate-gated channel protein activity, which comprises:

a) injecting into a host cell a population of nucleic acid molecules, at least of portion of which encodes a R. sanguineus GluCl channel protein selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:6 such that expression of said portion of nucleic acid molecules results in an active glutamate-gated channel;

b) contacting the host cell of (a) with a test compound;

c) in the presence and absence of the test compound, measuring host cell membrane current of (b) at a holding potential more positive than the reversal potential for chloride; and

d) comparing the currents measured in (c),

wherein if the current in the presence of the test compound is greater or less than the current in the absence of the test compound, a compound that modulates glutamate-gated channel protein activity is identified.

4. The method of claim 2 wherein said nucleic acid molecule is selected from the group consisting of complementary DNA, poly A+ messenger RNA and complementary RNA.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 039038/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2008
From: WARMKE, JEFFREY W; YANG, YOUFENG; CULLY, DORIS F; HAMELIN, MICHEL J
To: MERIAL LIMITED
Reel/Frame 021302/0523 →